Legacy Financial Advisors Inc. lifted its position in Danaher Co. (NYSE:DHR – Free Report) by 5.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,585 shares of the conglomerate’s stock after acquiring an additional 127 shares during the period. Legacy Financial Advisors Inc.’s holdings in Danaher were worth $646,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Gilbert & Cook Inc. increased its stake in shares of Danaher by 4.9% in the fourth quarter. Gilbert & Cook Inc. now owns 1,830 shares of the conglomerate’s stock worth $423,000 after acquiring an additional 86 shares during the period. Accretive Wealth Partners LLC grew its position in Danaher by 12.9% during the 4th quarter. Accretive Wealth Partners LLC now owns 3,632 shares of the conglomerate’s stock worth $840,000 after purchasing an additional 414 shares during the period. Gryphon Financial Partners LLC raised its stake in shares of Danaher by 19.1% during the 4th quarter. Gryphon Financial Partners LLC now owns 2,917 shares of the conglomerate’s stock valued at $675,000 after buying an additional 468 shares during the last quarter. TrinityPoint Wealth LLC lifted its holdings in shares of Danaher by 12.4% in the 4th quarter. TrinityPoint Wealth LLC now owns 1,469 shares of the conglomerate’s stock valued at $340,000 after buying an additional 162 shares during the period. Finally, Aigen Investment Management LP purchased a new stake in shares of Danaher in the fourth quarter worth about $320,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Insiders Place Their Bets
In related news, SVP Brian W. Ellis sold 9,600 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $5,566,486.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Rainer Blair sold 9,007 shares of Danaher stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the sale, the chief executive officer now owns 97,983 shares of the company’s stock, valued at approximately $27,435,240. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Brian W. Ellis sold 9,600 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $5,566,486.80. The disclosure for this sale can be found here. Insiders sold 39,659 shares of company stock valued at $11,042,433 in the last three months. 11.10% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Research Report on DHR
Danaher Stock Performance
NYSE:DHR opened at $272.63 on Friday. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $281.70. The company has a market cap of $201.93 billion, a P/E ratio of 46.21, a P/E/G ratio of 4.48 and a beta of 0.83. The company has a current ratio of 1.43, a quick ratio of 1.04 and a debt-to-equity ratio of 0.33. The company’s 50-day moving average price is $267.62 and its 200-day moving average price is $257.16.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the previous year, the firm posted $2.05 EPS. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, sell-side analysts forecast that Danaher Co. will post 7.59 earnings per share for the current fiscal year.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.40%. The ex-dividend date of this dividend is Friday, September 27th. Danaher’s payout ratio is currently 18.31%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Which Wall Street Analysts are the Most Accurate?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- MarketBeat Week in Review – 9/16 – 9/20
- What is the NASDAQ Stock Exchange?
- Don’t Miss These 3 Retail Stocks for Fall Gains
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.